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The complement system and the Toll-like receptors
(TLRs) are two central arms of innate immunity that
are critical to host defense as well as the develop-
ment of adaptive immunity. Most pathogens activate
both complement and TLRs, suggesting the potential
for crosstalk between the two systems. We show here
that the complement-derived C5a anaphylatoxin neg-
atively regulates TLR4- and CD40-induced synthesis
of IL-12 family cytokines (IL-12, IL-23, and IL-27) from
inflammatory macrophages (Mfs) by extracellular
signal-regulated kinase- and phosphoinositide 3 ki-
nase-dependent pathways. This decreased cytokine
response translates into a decreased T helper type 1
(Th1) response in vitro and in vivo. Accordingly, we
found enhanced Th1 immunity in C5a receptor-defi-
cient mice, something that conferred protection from
Leishmania major infection. Our findings identify the
negative impact of C5a on IL-12 family cytokines as
an important mechanism for regulating Th1 polariza-
tion in response to innate and adaptive immune net-
work activation.
Introduction
The innate immune system recognizes microbes by
their expression of unique molecular structures that do
not occur in the host. These invariant structures re-
ferred to as pathogen-associated molecular patterns
(PAMPs) are recognized by pattern recognition recep-
tors (PRRs) of the innate immune system. The comple-
ment system and the TLRs are two central arms of in-
nate immunity that have the ability to recognize PAMPs
and to destroy microbial invaders.
Lipopolysaccharide (LPS) from gram-negative bacte-
ria is a prototype PAMP that interacts with a cellular
LPS-recognition complex. TLR4 plays a dominant sig-
naling role in this complex, as it is able to bind distinct
adaptor molecules that drive the cellular response
(Akira and Takeda, 2004). In antigen-presenting cells
(APCs), ligation of TLR4 induces the production of IL-*Correspondence: joerg.koehl@chmcc.org
4 Present address: Pediatric Allergology and Pulmonology, Martin
Luther University Halle/Wittenberg, Halle 06099, Germany.12, a heterodimeric proinflammatory cytokine that pro-
vides a critical link between innate resistance and
adaptive immunity (Trinchieri, 2003). Of the multiple im-
munomodulatory functions of IL-12, two are of particu-
lar importance for the early phase of innate immunity
and the later adaptive immune response to pathogens:
the induction of interferon-γ (IFN-γ) from resting CD8+ T
cells and NK cells and the polarization of naive Th cells
toward Th1 effector cells. IFN-γ plays a key role in Mf
activation; which is critical for control of intracellular
pathogens (Gordon, 2003).
In addition to IL-12, two other heterodimeric cyto-
kines, IL-23 and IL-27, have recently been described
that establish the IL-12 family of cytokines (Trinchieri,
2003). Data accumulated from recent publications sug-
gest that some of the multiple immunoregulatory activi-
ties previously accredited to IL-12 are provided by IL-
27 and/or IL-23. As such, IL-27 exerts pro- as well as
anti-inflammatory properties (Villarino et al., 2004). IL-
23 has a major role in mediating and maintaining
chronic inflammation (Cua et al., 2003) by activation of
a specific IL-23 receptor on inflammatory Mf. In con-
trast to IL-12, IL-23 promotes proliferation of murine
memory T cells, suggesting that IL-23 contributes to
the maintenance of Th1-committed memory T cells
(Oppmann et al., 2000). In addition to TLR4 signaling,
CD40 signaling is of critical importance for the induc-
tion of IL-12 family cytokines and the development of
Th1 adaptive immune responses. CD40 is expressed by
APCs and becomes activated by crosslinking with
CD40 ligand on T cells as an important feedback mech-
anism between activated T cells and APCs. Importantly,
microbial priming of APCs is required to induce CD40
expression as a prerequisite for CD40 ligand-induced
production of IL-12 (Schulz et al., 2000).
Obviously, excessive or inappropriate production of
IL-12 family cytokines in response to PRR or CD40 li-
gand activation can become harmful to the host, result-
ing in endotoxic shock (Trinchieri, 2003). Further, it can
lead to imbalanced Th1-Th2 immune responses affect-
ing antiparasitic immunity (Sacks and Sher, 2002) and
the development of autoimmune diseases (Yadav and
Sarvetnick, 2003). To prevent such undesirable out-
comes, gate-keeping systems have evolved that func-
tion as endogenous regulators of TLR signaling path-
ways, which control the magnitude of IL-12 cytokine
family production (Akira and Takeda, 2004). Importantly,
this kind of regulation appears to be critical during the
second or continuous exposure to microorganisms. In
contrast, less is known about pathways that directly
impact TLR signaling during first encounters with path-
ogens.
Complement activation is one of the earliest innate
immune responses induced by pathogens. The first evi-
dence of a regulatory link between the complement
system and TLR-mediated immune responses was pro-
vided by reports demonstrating that activation of com-
plement receptor 3 (CR3) (Marth and Kelsall, 1997) and
the complement regulator molecule CD46 (Karp et al.,
1996) by C3 cleavage products promotes efficient con-
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cytes. Further, the C5 cleavage fragment C5a was u
found to downregulate LPS- and Staphylococcus f
aureus Cowan strain I (SAC)-induced synthesis of IL- s
12 in human monocytes, but not in monocyte-derived I
dendritic cells (DCs) (Braun et al., 2000; Wittmann et al., t
1999). In contrast, ablation of C5 in murine Mfs leads p
to reduced IL-12 production in response to IFN-γ + SAC C
stimulation, suggesting that C5a can enhance IL-12 T
production (Karp et al., 2000). These conflicting data o
suggest a complex, cell-dependent role of C5a in IL-12 t
regulation. The underlying molecular mechanisms and s
the consequences of such regulation on adaptive im- m
munity and infection remain elusive.
We show here that C5a has a negative impact on a
TLR4-induced synthesis of IL-12, IL-23, and IL-27 and l
provide evidence that C5aR signaling pathways com- a
prising extracellular signal-regulated kinase (ERK) and n
PI3K are of critical importance for this regulation. In ad- e
dition to its role in dampening TLR4-driven synthesis, I
C5a also regulates CD40-induced IL-12 family cytokine a
production through the signaling intermediate ERK1/2. p
Our data further identify IFN regulatory factor 1 (IRF-1) a
and IFN consensus sequence binding protein (ICSBP; m
IRF-8) as crucial transcription factors downstream of d
ERK and PI3K pathways, respectively. These data indi- 1
cate that C5a modulates both innate (TLR4) and adap- 2
tive (CD40) immune responses that drive the prod- I
uction of IL-12 family cytokines. These findings i
translated into a suppressive effect of C5a on Th1 po- (
larization, the in vivo relevance of which was docu- (
mented by the acquisition of resistance to Leishmania 1
major infection by the genetic deficiency of the C5a (




C5a Downregulates TLR4-Induced Expression c
of IL-12 Family Cytokines o
We investigated the effect of C5a receptor (C5aR) sig-
naling on TLR4-induced IL-12 family cytokine prod- Cuction from thioglycollate-elicited and IFNγ-primed
tMfs. Cells were stimulated with LPS from 1.5 to 24 hr
Cin the presence or absence of C5a (Figure 1A). Consis-
Ctent with previous data (Trinchieri, 2003), LPS induced
othe expression of high levels of IL-12p70, with a maxi-
emum 16 hr after stimulation. No IL-12p70 secretion was
idetected in unstimulated Mfs or Mfs that were treated
iwith C5a alone (data not shown). In accordance with
bdata obtained with human monocytes (Braun et al.,
a2000; Wittmann et al., 1999), IL-12p70 production in
smurine Mfs was significantly inhibited by preincubation
awith C5a in a time- (Figure 1A) and dose-dependent
o(Figure 1B) manner. In addition to C5a, the C3a anaphy-
mlatoxin negatively regulated IL-12p70 production (Fig-
sure 1C), albeit to a lesser extent than C5a (31% versus
(84% at 200 nM). In contrast, the chemokines CCL2 and
nCXCL2 had no effect, whereas CCL3 significantly in-
(creased IL-12p70 production (Figure 1D). C5a had no
fimpact on TLR4-induced release of IL-12p70 in C5aR−/−
pmice (Figure 1C), strongly suggesting that the regula-
gtory effect relates specifically to C5aR signaling and not
to the recently described second receptor for C5a C5L2
(Cain and Monk, 2002). iNext, we assessed whether IFN-γ priming is a prereq-
isite for the inhibitory effect of C5a on IL-12p70. We
ound substantial production of IL-12p70 in Mfs in re-
ponse to LPS without prior IFN-γ priming (Figure 1C).
mportantly, preincubation with C5a inhibited the syn-
hesis of IL-12p70, suggesting that exogenous IFN-γ
riming is not a prerequisite for the inhibitory effect of
5a on IL-12p70 production from elicited Mfs. Further,
LR4 activation in unprimed Mfs induced the release
f significant amounts of IFN-γ, which were substan-
ially reduced (66%) in the presence of C5a in C5aR-
ufficient mice (Figure 1F), but not in C5aR-deficient
ice (data not shown).
IL-12 is a heterodimeric cytokine comprising the p35
nd the p40 subunits, both of which are largely regu-
ated at the level of transcription (Liu et al., 2003). In
ddition to IL-12, two other heterodimeric cytokines,
amed IL-23 (Oppmann et al., 2000) and IL-27 (Pflanz
t al., 2002), have been identified. IL-27 consists of an
L-12p40-related protein, EBV-induced gene 3 (EBI3),
nd the newly discovered IL-12 p35-related protein
28, whereas IL-23 comprises the p40 subunit associ-
ted with an IL12 p35-related protein, p19. To deter-
ine a possible impact of C5a on the expression of
ifferent IL-12 family cytokine genes, we assessed IL-
2/IL-23p40, IL-12p35, IL-27p28, IL-23p19, and IL-
7EBI3 mRNA levels by quantitative real-time PCR. All
L-12 cytokine genes were upregulated by TLR4 signal-
ng, although to different extents, except IL-27EBI3
Figure 1G). The strongest effect was on IL-12p40
6500- to 17,000-fold) followed by IL-12p35 (400- to
300-fold), IL-27p28 (460- to 900-fold), and IL-23p19
150- to 490-fold). C5a markedly inhibited the upregula-
ion of all IL-12 family cytokine genes, indicating that
5a regulates IL-12 family expression at the mRNA
evel. This is not a general suppressive effect of C5a on
fs, as we found no suppressive effect of C5a on other
ytokines induced by TLR4 activation such as TNF-α
r IL-10 (data not shown).
5a Regulates Expression of IL-12 Family Cytokines
hrough Activation of PI3K and ERK1/2
5a exerts its effector functions by ligating a specific
5aR (CD88), which belongs to the large superfamily
f G protein-coupled receptors (GPCRs). Many of the
ffector functions of C5a are entirely sensitive to block-
ng of the Gαi subunit by pertussis toxin (PTX); however,
nhibition of IL-12 in human monocytes is only partially
locked by this treatment (Braun et al., 2000). We found
similar effect of PTX treatment by using murine Mfs,
upporting the view that in addition to Gαi, other Gα
nd the β/γ subunits contribute to the inhibitory effect
f C5a on IL-12p70 expression (data not shown). In hu-
an neutrophils, C5aR can couple to Gαi and Gα16, re-
ulting in activation of the Ras-Raf-MEK-ERK pathway
Buhl et al., 1995). Further, C5aR triggering in human
eutrophils was suggested to activate class IB PI3K
PI3Kγ) (Perianayagam et al., 2002). PI3Kγ belongs to a
amily of lipid kinases involved in generating distinct
hosphoinositides that are important second messen-
ers for intracellular signaling (Koyasu, 2003).
To identify the signaling pathways that mediate the
nhibition of the different IL-12 family subunits (Figure
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417Figure 1. C5a Negatively Regulates TLR4-Induced IL-12 Family Cytokines and IFN-γ
(A and B) Time- (A) and dose-dependent (B) downregulation of IL-12p70 production from IFN-γ-primed Mfs. Cells were stimulated with LPS
(100 ng/ml) in the absence or presence of C5a (50 nM) and incubated for the indicated times.
(C) Impact of C5a and C3a on LPS-induced IL-12p70 production from IFN-γ-primed Mfs of C5aR−/− mice.
(D) Impact of C5a, CCL2, CCL3, and CXCL2 on TLR-4-induced IL-12p70 production. All reagents were used at a concentration of 50 nM.
(E and F) Dose-dependent inhibition of IL-12p70 (E) and IFN-γ (F) secretion from unprimed Mfs.
(G) mRNA expression levels of IL-12 family cytokine subunits in IFN-γ-primed Mfs quantified by real-time RT-PCR. Data are depicted as
expression levels relative to expression in unstimulated Mfs.
Values shown are the mean ± SEM of at least three experiments. *p < 0.05; **p < 0.005.1G), we pharmacologically targeted PI3K and ERK1/2,
as activation of either molecule has been associated
with inhibition of TLR-induced IL-12 production. Class
IA PI3K can act as an endogenous negative regulator of
TLR4 signaling in DCs (Fukao et al., 2002), probably byblocking p38MAPK activation. LPS-activated ERK1/2
can downregulate the expression of the transcription
factor IRF-1 (Goodridge et al., 2003), an important in-
ducer of IL-12p35 transcription (Liu et al., 2003). We
found that C5a time-dependently activated PI3K (Fig-
Immunity
418Figure 2. C5a Regulates IL-12 Family Cytokine Expression through Activation of ERK1/2 and PI3K
(A) C5a-induced PIP3 formation. IFN-γ-primed Mfs were stimulated with C5a (50 nM) for 30 s and 5 min, and PIP3 formation was determined
by an anti-PIP3 specific mAb (white histogram) in relation to PIP3 formation in unstimulated cells (gray histogram) by flow cytometry.
(B) C5a-induced activation of ERK1/2. IFNγ-primed Mfs were stimulated with C5a (50 nM) for the indicated times, and cell lysates were
analyzed by Western blotting using anti-phospho ERK1/2-specific Ab. Equal loading of the gel was confirmed by reprobing the stripped
membrane with ERK1/2-specific Ab.
(C) Contribution of PI3K to the inhibitory effect of C5a on IL-12 family cytokine subunit mRNA expression. mRNA expression was quantified
by real-time RT-PCR. Expression levels in cells stimulated with LPS are set 100%. ns, not significant.
(D and E) Contribution of PI3K (D) and contribution of ERK1/2 (E) to the inhibitory effect of C5a on IL-12p70 production. IFN-γ-primed Mfs
were treated with the indicated concentrations of the PI3K inhibitor wortmannin or the MEK1/2 inhibitor U0126 1hr prior to stimulation with
LPS (100 ng/ml) or LPS/C5a (200 nM). IL-12p70 levels in supernatants were examined 16 hr after cell stimulation by ELISA.
Values shown are the mean ±SEM of at least three experiments. *p < 0.05; **p < 0.005.ure 2A) and ERK1/2 (Figure 2B), indicating that CD88 P
ksignaling may amplify the effect of these endogenous
inhibitory pathways. First, to assess the contribution of uI3K on LPS-induced production of IL-12 family cyto-
ines, we blocked the function of this molecule by
sing wortmannin. This treatment increased mRNA
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419synthesis of IL-12/IL-23p40, IL-12p35, and IL-23p19,
but not that of IL-27p28, suggesting that PI3K regulates
TLR4-induced IL-12 and IL-23 production, but not that
of IL-27. Further, PI3K blockade had a strong impact on
the inhibitory effect of C5a on IL-12/IL-23p40 and IL-
23p19, whereas the inhibitory effect on IL-12p35 and
IL-27p28 was not significantly affected (Figure 2C).
These data suggest that C5aR signaling has a negative
impact on TLR4-induced IL-23 production by a PI3K-
dependent pathway. Further, our findings indicate a role
for PI3K in C5a-mediated inhibition of IL-12, whereas
the regulation of IL-27 is PI3K independent. As only the
p40 subunit of biologically active IL-12 was suppressed
by C5a-induced PI3K, it remained unclear whether this
effect would impact the formation of the IL-12p70 het-
erodimer. Thus, we determined the expression of IL-
12p70 in response to TLR4 activation in the presence
of C5a and wortmannin. Similar to what has been found
with murine DCs (Fukao et al., 2002), LPS-induced IL-
12p70 secretion from Mfs was dose-dependently en-
hanced. However, wortmannin treatment had no impact
on the inhibitory effect of C5a on TLR4-induced IL-
12p70 (Figure 2D). These data suggest that the en-
hanced production of IL-12p70 in response to PI3K in-
hibition depends on increased IL-12p35 expression,
which is consistent with a previous report that IL-12p70
formation is limited by IL-12p35 (Snijders et al., 1996).
Accordingly, the C5a-induced inhibition of IL-12p70 is
independent of its PI3K-mediated negative regulation
of IL-12/IL-23p40.
In a search for signaling pathways that may account for
the effect of C5a on IL-12p70, we focused on ERK1/2.
As expected (Hacker et al., 1999), blockade of MEK1/2
dose-dependently increased the production of IL-
12p70. Importantly, pharmacological targeting of the
MEK-ERK pathway, by using the MEK1/2-specific in-
hibitor U0126, abrogated the inhibitory effect of C5a
(Figure 2E), suggesting that activation of ERK1/2 nega-
tively regulates IL-12p35 expression as the critical
mechanism by which C5a impacts IL-12p70. Impor-
tantly, the control molecule U0124 had no impact on
the negative regulatory effect of C5a, suggesting that
the effect was MEK-ERK specific (data not shown). The
inhibitory effect of C5a is independent of IL-10, as C5a
blocked IL-12p70 production from Mfs of IL-10-defi-
cient mice and from mice that had been treated with an
anti-IL-10R antibody (data not shown).
C5a Inhibits TLR4-Induced Upregulation
of IRF-1 and ICSBP
In murine Mfs, activation of TLR4 and TLR9 induces
ERK activity through a MEK1/2-dependent pathway
(Hacker et al., 1999). Recent data suggest a link be-
tween ERK activity and the regulation of IRFs, which
have been implicated to be important transcription
factors for IFN-γ-primed and TLR4-induced IL-12p35
and IL-12/IL-23p40 transcription, respectively (Liu et
al., 2003; Wang et al., 2000). Available data from the
literature suggest a model in which p35 transcription is
mainly regulated by IRF-1 (Liu et al., 2003), whereas the
transcription of the IL-12/IL-23p40 subunit depends
mainly on ICSBP (Wang et al., 2000) and to some extent
to IRF-1 (Maruyama et al., 2003; Wang et al., 2000). Im-portantly, ERK phosphorylation has been found to sup-
press the synthesis of IRF-1 (Goodridge et al., 2003).
Based on these data, we hypothesized that C5a sup-
presses IRF-1 by an ERK1/2-dependent mechanism. As
depicted in Figure 3, mRNA expression of IRF-1 was
markedly inhibited when IFN-γ-primed Mfs had been
stimulated with LPS in the presence of C5a. Further,
C5a treatment suppressed the induction of ICSBP.
These findings indicate that a C5aR signaling pathway
comprising MEK1/2-ERK1/2-IRF-1 promotes inhibition
of IL-12p35 transcription, the net effect of which is a
reduced production of IL-12p70. Based on our findings
that C5a inhibits production of IL-12/IL-23p40 through
activation of PI3K (Figure 2C) and the fact that ICSBP
regulates transcription of IL-12/IL-23p40 (Wang et al.,
2000), we further suggest a C5aR signaling pathway in
which PI3K blocks the production of IL-12/IL-23p40
through inhibition of ICSBP.
C5a Blocks CD40-Enhanced IL-12p70 Production
through an ERK1/2-Dependent Pathway
In addition to TLR4 ligation, CD40 crosslinking on Mfs
and DCs by CD40 ligand expressed by T cells can in-
duce IL-12 production. This pathway critically depends
on prior priming through microbial stimuli (Schulz et al.,
2000) ensuring that APCs produce high levels of IL-
12p70 only during APC-T cell interactions after the ap-
propriate type of infection. We found a tremendous in-
crease of IL-12p70 production in IFN-γ-primed Mfs that
had been treated with a combination of LPS and an
agonistic anti-CD40 antibody over that observed in
Mfs treated with LPS alone (Figure 4A). Importantly, IL-
12p70 production was almost abrogated when C5a was
present during TLR4/CD40 stimulation.
CD40 signals through several pathways, including
ERK1/2 and PI3K, both of which are relevant to the in-
hibitory effect of C5a on TLR4-induced production ofFigure 3. C5a Downregulates the TLR4-Induced Transcription
Factors IRF-1 and ICSBP
IFN-γ-primed Mfs were stimulated with LPS (100 ng/ml) or LPS/
C5a (50 nM) for 3 hr. mRNA expression was quantified by real-
time RT-PCR and is shown as the expression level relative to the
expression in unstimulated cells.

























































Figure 4. C5a Regulates CD40-Induced IL-12p70 Expression
through Activation of ERK1/2
(A) CD40-induced IL-12p70 expression from IFN-γ-primed Mfs
ostimulated with LPS (100 ng/ml), C5a (200 nM), anti-CD40 antibody
t(10 ug/ml), or an isotype-matched control antibody (Isotpye Ctrl).
(IL-12p70 concentrations were determined from supernatants har-
Vvested 16 hr after cell stimulation.
*(B and C) Impact of PI3K inhibition (B) and MEK1/2 inhibition (C)L-12 family cytokines. Blockade of PI3K resulted in a
arked increase of IL-12p70 in IFN-γ-primed Mfs that
ad been treated with LPS and anti-CD40. Despite this
ubstantial increase in IL-12p70 production, C5a al-
ost completely blocked the production of IL-12p70 in
he presence of wortmannin (Figure 4B). Similar to PI3K
nhibition, IL-12p70 production substantially increased
n response to MEK1/2 blockade with U0126 (Figure
C). Importantly, MEK1/2 blockade by U0126 abolished
he inhibitory effect of C5a (Figure 4C), whereas the ad-
inistration of the control molecule U0124 had no ef-
ect (data not shown). Together, these data suggest that
5aR signaling through MEK1/2-ERK, but not through
I3K, is of critical importance for C5a-mediated inhibi-
ion of CD40-induced IL-12p70 production.
5a Negatively Impacts Th1 Polarization
n Vitro and In Vivo
he potent inhibition of IL-12 family cytokine produc-
ion by C5a in response to both TLR4 and CD40 activa-
ion prompted us to investigate whether C5a impacts
olarization of naive T cells toward a Th1 phenotype.
e stimulated naive OVA323–339-specific TCR trans-
enic CD4+ T cells with IFN-γ-primed Mfs that had
een pulsed with different concentrations of OVA323–339
eptide and LPS in the presence or absence of C5a.
e found huge concentrations of IFN-γ but no IL-4 in
he supernatants of Mf and CD4+ T cell cocultures, the
agnitude of which was dependent on the amount of
VA323–339 peptide (Figure 5A). In the presence of C5a,
FN-γ secretion was substantially reduced. No IL-4 prod-
ction was measurable. Culturing Mfs or CD4+ T cells
lone did not result in any measurable IFN-γ release. Simi-
arly, intracellular production of IFN-γ in OVA-specific
D4+ T cells was reduced from 22.9% to 14.8%. Very few
ells produced IL-4 (0.9%), the percentage of which
emained unchanged (0.7%) after C5a treatment (Figure
B). Thus, C5a attenuates Mf-induced Th1 skewing in vitro.
In vivo, IL-12-dependent Th1 immune responses are
ritical for protective immunity against intracellular
athogens such as Leishmania major. Importantly, Mfs
nfected with Leishmania have lost their ability to pro-
uce IL-12 in response to TLR4 and CD40 activation
Sacks and Sher, 2002). Based on our in vitro data, we
ypothesized that C5aR signaling contributes to the
mpaired IL-12 production and the consecutive failure
f mounting protective Th1 immunity in response to
eishmania infection. We tested this hypothesis in the
ell-characterized murine model of dermal L. major in-
ection (Belkaid et al., 2002a) by using C5aR-deficient
ice (C5aR−/−) backcrossed to the highly susceptible
ALB/c background. First, we determined the impact
f C5aR signaling on the cutaneous inflammatory re-
ponse. C5aR−/− mice were more resistant to L. major
nfection as compared with wild-type (wt) BALB/c mice
s demonstrated by the absence of necrotizing dermaln CD40-induced IL-12p70 production. Cells were incubated with
he PI3K inhibitor wortmannin (100 nM) or MEK1/2 inhibitor U0126
10 M) 1 hr prior to stimulation.
alues shown are the mean ±SEM of at least three experiments.
p < 0.05; **p < 0.005.
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421Figure 5. C5a Inhibits Th1 Polarization In Vitro
(A) Impact of C5a on IFN-γ production from OVA-specific CD4+ T
cells isolated from TCR-DO11.10/RAG2 [KO] mice. T cells were co-
cultured with OVA322–339 pulsed and LPS (100 ng/ml) stimulated
Mfs for 5 days and restimulated with freshly pulsed Mfs for an-
other 3 days in the absence or the presence of C5a. C5a and
OVA322–339 were used at the indicated concentrations. Cytokine
production was determined by ELISA.
(B) As in (A) except that the cytokine profile was determined by
intracellular cytokine staining for IFN-γ and IL-4 using flow cytom-
etry.
Values shown are the mean ±SEM of at least three experiments.
**p < 0.005.lesions (Figure 6A). This protective effect was associ-
ated with a significant reduction in parasite numbers
in the ear (10-fold) and in the draining lymph nodes
(3-fold; Figure 6B). Further, numbers of CD4+ and CD8+
T cells were significantly increased in draining lymph
nodes of C5aR−/− mice as compared with BALB/c con-
trols (Figure 6C). Recall of lymph node cells with L. ma-
jor Ag induced considerable production of the Th1 cy-
tokine IFN-γ in C5aR−/− mice, but not in BALB/c
controls. In contrast, the production of the Th2 cytokine
IL-4 from lymph node cells of C5aR−/− was reduced as
compared with the production of cells from BALB/c
controls (Figure 6D). Although our data provide no di-
rect evidence that Th1 skewing is caused by the lack
of C5aR-signaling specifically in Mfs, they strongly
support the view that C5a plays a critical role in nega-tive regulation of IL-12 family cytokines in vivo, which
ultimately controls the development of type 1 immunity
in L. major infection.
Discussion
The production of IL-12 in response to pathogen-induced
activation of TLR4 provides a critical link between in-
nate and adaptive immune responses. Clearly, the
pleiotropic activities of IL-12 on NK cell, T cell, and B
cell function warrant tight control to assure appropriate
innate and adaptive immune responses. In addition to
the multiple endogenous inhibitory pathways down-
stream of TLR4 signaling (reviewed in Akira and Takeda
[2004]), activation of complement receptors that bind
C3 cleavage products have been described to control
TLR4-mediated IL-12 release (Karp et al., 1996; Marth
and Kelsall, 1997). More recently, C5aR signaling has
also been implicated in negative regulation of TLR-
induced IL-12 synthesis (Wittmann et al., 1999), al-
though opposite effects have been reported as well
(Karp et al., 2000). Our data support the view that C5a
is a negative regulator of IL-12 production. In contrast
to previous data obtained with human monocytes, we
found that the negative regulatory effect of C5a in mu-
rine Mfs is independent of IFN-γ priming, suggesting
distinct species and/or cell-specific mechanisms (sig-
naling pathways). Our data are in apparent contrast to
findings that suggest a positive impact of C5aR signal-
ing on IL-12 production by human monocytes and mu-
rine Mfs in response to SAC stimulation (Karp et al.,
2000). SAC is a crude mixture of molecules that is likely
to activate TLR2 and multiple other, poorly defined sig-
naling pathways. C5a may synergize with TLR-indepen-
dent pathways that are important for SAC-induced
production of IL-12. Notably, our data demonstrate that
C3a also negatively regulates IL-12 production (although
at a lower potency), suggesting that C3aR shares to
some extent a GαI signaling pathway with the C5aR
in murine Mfs. CCL2, CCL3, and CXCL2, all of which
activate GPCR (CCR2, CCR5, and CXCR2) that can
couple to Gαi, had either no impact or did increase
(CCL3) IL-12p70 production in murine Mfs. Our find-
ings are in contrast to data showing that CCL2 nega-
tively regulates bacterial-induced IL-12 production in
human monocytes (Braun et al., 2000) but are in agree-
ment with the finding that parasite-induced activation
of CCR5 promotes IL-12 production in murine DCs
(Aliberti et al., 2003). Apparently, a tremendous plastic-
ity of cell and/or species-specific coupling of distinct G
protein has evolved, determining activation of distinct
signaling cascades that eventually lead to positive or
negative regulation of microbial-driven IL-12 prod-
uction.
In light of the recent discovery of IL-23 and IL-27, it
is now clear that IL-12 is only one member of a growing
family of heterodimeric cytokines at the interface be-
tween innate and adaptive immunity. Importantly, IL-23
and IL-27 are not mere copycat cytokines that share
many functions with IL-12 but have unique functions
that are not redundant with IL-12. Data obtained with
mice lacking the IL-23-specific subunit p19 (Cua et al.,
2003) emphasize a major role for IL-23 in macrophage-
Immunity
422Figure 6. C5aR-Deficient BALB/c Mice Are
Almost Resistant and Show a Th1 Response
in Response to L. major Infection
(A) Appearance of lesions at the inoculation
site 7 weeks postinfection.
(B) Number of parasites in L. major-infected
C5aR−/− and wt mice. Parasite numbers in ear
tissue and draining lymph nodes from L. ma-
jor-infected mice were determined 4 weeks
postinfection.
(C) Numbers of CD4+ and CD8+ T cells in ear
tissue from L. major-infected mice. Cell num-
bers were calculated from total cell numbers
in the ear.
(D) Cytokine secretion from lymph node cells
4 weeks postinfection. Cells from draining
nodes were restimulated with soluble Leish-
mania antigen for 72 hr. Cytokine production
in the supernatants was examined by spe-
cific ELISA.
Values shown are the mean ±SEM of at least
three experiments. *p < 0.05; **p < 0.005.mediated inflammation, but not in Th1 polarization, pro- s
Pviding an explanation for the finding that p40-deficient
mice (lacking IL-12 and IL-23) and IL-12Rβ1-deficient n
cmice (lacking the common subunit of IL-12 and IL-23
receptors) are protected from autoimmune disease, p
cwhereas p35- and IL-12Rβ2-deficient mice (the latter
lacking the IL-12R-specific subunit) are more suscepti- a
ible than wt mice (Trinchieri, 2003). Our data demon-
strate that in addition to its role as a negative regulator M
eof IL-12 production, C5a also suppresses TLR4-induced
synthesis of IL-23 and IL-27. Such broad inhibition is d
clikely to affect the host response to infection and to
modulate autoimmunity. In support of this view, a d
mcentral role of C5/C5a was suggested in the pathogen-
esis of autoimmune arthritis (Ji et al., 2002), systemic l
lupus (Wang et al., 1996), DTH responses (Tsuji et al.,
2000), and allergy (Karp et al., 2000), as well as in resis- s
Itance to Listeria (Gervais et al., 1989) and to blood
stage-malaria infection (Sam and Stevenson, 1999). t
pCommon to all of these models is their dependency on
or exacerbation by IL-12 family cytokines. M
nThe signaling pathways underlying the synthesis of
the different subunits of IL-12 family cytokines down- u
cstream of TLR4 activation are complex and involve sev-
eral distinct adaptor molecules, the assembly of which t
pactivates the NF-κB family of transcription factors and/
or MAPKs (Akira and Takeda, 2004). The contribution of f
iPI3K in this signaling pathway is controversial. Acti-
vated class IA PI3K has the ability to form a complex v
with tyrosine-phosphorylated adaptor molecule my-
eloid differentiation primary-response protein (MyD88) p
rin response to TLR4 triggering (Akira and Takeda,
2004). A study using a dominant negative mutant of the a
mp85 subunit of PI3K suggested that class IA PI3K is a
positive mediator of TLR4 signaling that activates NF- C
pκB (Li et al., 2003). In contrast, targeting class IA PI3K
increases the activity of p38 MAPK, which is critical for m
Ctranscriptional activation of both IL-12p35 and IL-12/IL-
23p40 genes (Fukao et al., 2002; Lu et al., 1999). Ac- t
ncordingly, IL-12/IL-23p40 and IL-12p35 production washown to be markedly enhanced in DCs of class IA
I3K-deficient mice (Fukao et al., 2002), suggesting
egative feedback regulation of IL-12 production by
lass IA PI3K. Our data support the latter finding, as
harmacological targeting of PI3K in murine Mfs in-
reased mRNA synthesis of IL-12/IL-23p40, IL-12p35,
nd IL-23p19. Importantly, we found that C5aR signal-
ng induces class IB PI3K activation in inflammatory
fs, the blockade of which suppressed the inhibitory
ffect of C5a on IL-12/IL23p40 and IL-23p19. These
ata suggest that both PI3K isoforms, class IA and
lass IB, control the production of IL-12p40. Further, our
ata identify C5aR signaling as an important upstream
echanism to activate PI3K, which negatively regu-
ates TLR4-induced synthesis of IL-12p40 and IL-23.
In addition to PI3K activation, ERK activation was de-
cribed to selectively inhibit TLR-induced production of
L-12 in Mfs (Hacker et al., 1999). In agreement with
he inhibitory role of ERK, we found increased IL-12p70
roduction in response to pharmacological targeting of
EK1/2. Importantly, targeting MEK1/2 abrogated the
egative regulatory effect of C5a on IL-12p70 prod-
ction, indicating that ERK1/2 phosphorylation is cru-
ial to this effect. In contrast to data suggesting that
he inhibitory effect of ERK on IL-12 production de-
ends on the production of IL-10 (Yi et al., 2002), we
ound the negative impact of C5a on IL-12 production
n Mfs to be independent of IL-10, as suggested pre-
iously (Braun et al., 2000; Wittmann et al., 1999).
The strong, negative impact of complement cleavage
roducts on IL-12 production suggests an important
ole of complement in the control of T cell-mediated
daptive immunity, in particular in Th cell lineage com-
itment. To date, no data are available that link CR3-,
D46-, or C5a-mediated suppression of IL-12 to im-
aired Th1 skewing. By using the well-established
odel of OVA-induced Th1 polarization, we found that
5a suppresses Th1 lineage commitment. In addition
o microbial priming via TLR, the concentration and the
ature of the antigen, Th cell lineage commitment criti-
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423cally depends on bidirectional signaling between APCs
and T cells. As such, CD40 acts as an important co-
stimulatory molecule on APCs to activate Th cells. Vice
versa, activated Th cells stimulate APCs through CD40-
CD40 ligand interaction as an important positive feed-
back mechanism amplifying IL-12 production from
APCs. Our data provide evidence that this positive
feedback mechanism is restrained in the presence of
C5a as a second means (in addition to the effect on
TLR4) by which C5a suppresses Th1 polarization. Im-
portantly, our data are in contrast to a previous report
in which C5a was found to have no impact on CD40
ligand-induced IL-12 production in human monocyte-
derived DCs, despite C5aR expression (Braun et al.,
2000). Distinct, cell-specific signaling pathways in DCs
and Mfs are likely to account for these differences. The
strong impact on Th cell polarization suggests that C5a
acts not only at sites of inflammation to suppress IL-12
and IFN-γ but also plays an important role in the lymph
node to affect T cell priming.
Importantly, we demonstrate that activation of ERK1/2
is critical for the C5a effect on CD40 signaling, a path-
way that has been recently implicated in negative regu-
lation of CD40-induced IL-12 production in Leishmania
infection (Mathur et al., 2004) (see below). Although in-
triguing, it remains to be determined whether the inhibi-
tory effect of C5a in vivo requires ERK1/2 signaling.
Several intracellular pathogens like Leishmania, My-
cobacteria, Listeria, Histoplasma, and HIV activate the
complement cascade, become opsonized by C3b/
iC3b, use CR3-mediated phagocytosis to enter Mfs,
and induce the generation of C5a. One of the earliest
events in Leishmania infection is the binding of pro-
mastigotes to natural antibodies in blood and activation
of the classical pathway of complement (Dominguez et
al., 2002), resulting in C3 opsonization. Opsonized par-
asites can bind to CR1 on red blood cells (immune ad-
herence) and finally enter their preferred host cell, the
Mf, through CR3-mediated uptake (Sacks and Sher,
2002). This uptake through CR3 is considered an impor-
tant mechanism that contributes to the selective failure
of infected Mfs to produce IL-12 (Sacks and Sher,
2002). In addition to the activation of complement, re-
cent data suggest that Leishmania infection activates
TLR4 as an important mechanism to control parasite
replication (Kropf et al., 2004). Further, CD40-mediated
production of IL-12 and the production of IFN-γ from
Th1-polarized T cells are considered crucial for parasite
killing (Sacks and Sher, 2002). No data exist as to
whether Leishmania parasites exploit C5aR signaling
for immunoregulatory properties. Given the role of
C5aR signaling in regulating IL-12 family cytokine and
IFN-γ production, we hypothesized that Leishmania
takes advantage of the generation of C5a as an evasion
mechanism to avoid killing by the adaptive immune
system. Our data support this hypothesis by showing
that the local L. major infection is substantially reduced
in C5aR−/− mice as evidenced by reduced dermal lesion
and reduced parasite burden. Mechanistically, disease
improvement was associated with increased numbers
of CD4+ as well as CD8+ cells and a Th1-polarized im-
mune response. Importantly, IFN-γ release by CD8+
L. major-specific T cells was recently found to promotedevelopment of protective immunity (Belkaid et al.,
2002b).
In addition to IL-12, recent reports suggest a role for
IL-23 and IL-27 in leishmanial disease pathogenesis.
Mice deficient in the IL-27 receptor WSX-1 are highly
susceptible to L. major infection and suffer from im-
paired IFN-γ production early in the infection (Yoshida
et al., 2001). The critical role of IL-23 in macrophage-
mediated inflammation (Cua et al., 2003) indicates a
possible role of this cytokine in intracellular parasite
killing, although the contribution of IL-23 to infection
still awaits to be fully addressed. A recent study sug-
gests that IL-23 can enhance resistance to Toxoplasma
infection in the absence of IL-12 (Lieberman et al.,
2004). Thus, it is tempting to speculate that the benefi-
cial effect of C5aR deficiency on L. major infection is
not only entirely dependent on rebalanced IL-12 but
also on rebalanced IL-27 and/or IL-23 production.
Whatever the contribution of each of the IL-12 family
cytokines is, our data imply that L. major takes advan-
tage of the activation of one important defense mecha-
nism of innate immunity (the complement system) to
suppress cell-mediated immunity induced by another
crucial arm of innate immunity, i.e., the TLR system.
This immune evasion strategy may be used by other
intracellular pathogens as well, such as Mycobacteria,
Listeria, Histoplasma, or even HIV. Accordingly, specific
blockade of the C5aR may prove useful to prevent
pathogen-induced deprivation of IL-12 family cytokines
as a novel therapeutic immunointervention strategy.
Experimental Procedures
Mice
B10.D2/nSnJ and BALB/c mice were purchased from Jackson
Laboratories (Bar Harbor), and TCR transgenic DO11.10/RAG2 [KO]
mice were purchased from Taconic (Germantown). C5aR-deficient
mice (Gerard and Gerard, 1991) were backcrossed to the BALB/c
background (n = 7). All animals were held under SPF conditions.
Experimental groups were sex matched and 8–12 weeks of age. All
animal experiments were approved by the institutional animal care
and use committee of Cincinnati Children’s Hospital.
Generation of Elicited Peritoneal Mfs
B10.D2/nSnJ mice were injected i.p. with 2 ml thioglycollate (0.3%).
Elicited cells were harvested after 72 hr by peritoneal lavage with
cold PBS, washed twice with PBS, and resuspended in complete
medium (DMEM + FBS [10%] + 100 U/ml penicillin, and 100 g/ml
streptomycin). In some experiments, Mfs were purified from lavage
cells by flow cytometry. Briefly, cells were incubated with 2 l anti-
F4/80 or isotype control (conjugated to PE, Serotec) per 1 × 106
cells on ice for 30 min and sorted for FSC/SSC characteristics and
F4/80bright expression on a FACSVantage cell sorter to a purity of
>95%.
Flow Cytometric Analysis of Elicited Mfs
Expression of surface markers on sorted F4/80-positive Mfs was
analyzed by flow cytometry. Fc receptors were blocked with 2.4G2
antibody (5 g per 1 × 106 cells in PBS-FBS 0.1%) for 15 min on ice.
Cells were stained for 60 min on ice with the following antibodies or
the appropriate isotype controls (400 ng antibody per 1 × 106 cells
in PBS-FBS 0.1%): CD11b (clone M1/70), CD11c (clone HL3), Ly6G
(clone RB6-8C5; all antibodies were conjugated to FITC, BD Biosci-
ence), CD88 (conjugated to Alexa-488, a kind gift of Dr. Jörg
Zwirner, Göttingen), or biotinylated antimouse I-Ad (clone AMS-
32.1) stained with Streptavidin-CyChrome (1:3000, both from BD
Bioscience). Data were collected and analyzed by using
Immunity




DElicited Mfs (5 × 105 cells) were incubated in 250 l complete me-
1dium in 48-well plates for 2 hr at 37°C, 5% CO2. Endotoxin levels
(of all reagents were <0.03 IU as determined by LAL test (Bio Whit-
itacker). Nonadherent cells were removed by washing twice with
(PBS. Cells were primed with murine IFN-γ (40 ng/ml, Sigma-Aldrich)
mfor 2 hr in a total volume of 250 l and stimulated with LPS (100
ng/ml, Sigma, E.coli O127:B8). In some experiments, cells were
stimulated simultaneously with LPS and an agonistic anti-CD40 an- S
tibody (10 g/ml, clone FGK45). Further, repurified TLR4-specific I
LPS (Hirschfeld et al., 2000) (a kind gift of S.N. Vogel, Baltimore) d
was used for stimulation of Mfs in some experiments. Results ob- o
tained with repurified LPS were indistinguishable from data ob- h
tained with commercially available LPS. Recombinant human C5a s
(Sigma), human C3a (Advanced Research Technologies), CCL2, O
CCL3, and CXCL2 (all at 50 nM; all from PreproTech) were added t
to the culture 10 min prior to LPS challenge. Inhibitors for PI3K c
(Wortmannin, 6.25–100 nM), MEK1/2 (U0126, 0.625–20 M), and u
PTX (2 ug/ml; all from Calbiochem) were added 1 hr before stimula- t
tion. To ascertain that the effect of C5a was Mf derived, we re- u
peated some experiments obtained with adherent Mfs with Mfs p
gated on F4/80high expression and typical FSC/SSC characteristics. A
We found that the majority of such purified Mfs was CD11b+ f
(92.8%) and CD88+ (82.7%). Some cells expressed MHC II (22.8%), o
and a minor portion was CD11c+ (7.2%). All cells were Ly6G-. Re- m
sults obtained with purified Mfs were indistinguishable from those C
obtained with adherent Mfs, suggesting that the observed effects l
can be attributed to Mfs. b
a
wDetermination of Gene Expression Levels in Elicited Mfs
2–4 × 106 IFNγ-primed Mfs were stimulated with LPS and treated
with or without C5a (200 nM) or wortmannin (100 nM) for different L
times as described above. Cells were washed with PBS, and mRNA C
was prepared with TRIzol reagent (Invitrogen). cDNA was prepared p
from 2 g of DNAse-treated RNA by using SuperscriptII Reverse c
Transcriptase (Invitrogen) per the manufacturer’s protocol. Gene i
expression levels were determined by real-time RT-PCR using iQ- U
SYBRgreen reaction mix (BioRad) containing 5 l cDNA and 500 nM H
primer. The following primers were used with an annealing temper- t
ature of 58°C: Actin-β (183bp) (f) 5#-GAAATCGTGCGTGACATCAAAG- p
3#, (r) 5#-CCAAGAAGGAAGGCTGGAAAAG-3#; IL-12p40 (103bp) (f) 5#- 5
CAGAAGCTAACCATCTCCTGG-3#, (r) 5#-CAACATCTCCACCTGACC f
TGA-3#; IL-12p35 (256bp) (f) 5#-GATCATGAAGACATCACACGG-3#, f
(r) 5#-GTTGGTAGTCGTCTAGTAAGA-3#; and IL-23p19 (133bp) (f) 5#- u
AATAATGTGCCCCGTATCCAG-3#, (r) 5#-GAAGATGTCAGAGTCAA
GCAG-3#. Primers for IL-27p28,EBI-3 (Pflanz et al., 2002), IRF-1, P
IRF-2, and ICSBP (Barber et al., 1995) were used as described. P
Samples were analyzed on an iCycler Real-Time PCR System (Bi- a
oRad). Gene expression levels were normalized to Actin-β expres- s




IL-12p70, IFN-γ, and IL-4 concentrations in supernatants from stim- t
ulated Mfs or restimulated lymph node cells were determined by a
using Duo Set ELISA kits (R&D Systems) per the manufacturer’s i
protocol. Detection limits were 23.4 pg/ml (IL-12p70), 31.2 pg/ml b
(IFN-γ), and 15.6 pg/ml (IL-4). s
d
bDetermination of ERK1/2 phosphorylation
2 × 106 IFN-γ-primed Mfs were stimulated with C5a (50 nM) for
0.5–20 min. Cells were washed twice with cold PBS/orthovanadate C
C(2 mM), lysed in 50 l lysis buffer (1% Triton X-100, 5 mM EDTA, 50
mM NaCl, 50 mM NaF, 10 mM Tris/Cl [pH 7.6], 0.1% BSA, 10 g/ml F
sAprotinin, and 10 g/ml Leupeptin) and incubated 5 min on ice.
Lysates were cleared by centrifugation (25 min, 15,000 × g at 4°C), p
aapplied to 12% SDS PAGE, and analyzed by Western blotting using
a Phospho-p44/42 MAPKinase antibody (1/2000, clone 9101, Cell p
7Signaling) and anti-rabbit IgG HRP (1/2000, Cell Signaling). Signals
were visualized by ECL detection system (Amersham). Equal load- lng of the gel with protein was confirmed by reprobing the stripped
embrane with p44/42 MAPKinase antibody (1/2000, clone 9102,
ell Signaling).
etermination of PI3K Activation
× 106 IFNγ-primed Mfs were stimulated for 0–10 min with C5a
50 nM). Cells were fixed with paraformaldehyde (4%), permeabil-
zed with saponin (0.3%), incubated for 30 min with anti-PIP3 mAb
1/100, clone RC6F8, Molecular Probes), and stained with an anti-
ouse IgM-Cy3 conjugate (1/1000, Jackson).
timulation of OVA-Specific CD4+ T Cells with Mfs
FN-γ-primed Mfs (2.5 × 105) were cultured in 250 l complete me-
ium in 48-well plates and stimulated with LPS (100 ng/ml) and 10
r 1 g/ml OVA323–339 (Jerini Peptide Technology, Berlin) for 48
r. In some experiments, C5a (50 nM) was added 10 min prior to
timulation. DO11.10/RAG2 [KO] mice (Taconic) transgenic for an
VA323–339-specific αβTCR and deficient in the recombinase activa-
ing gene 2 (Rag2) were used as a source of antigen-specific T
ells. CD4+ T cells were positively selected from spleen cells by
sing CD4 (L3T4) MicroBeads (Miltenyi) according to the manufac-
urer’s protocol. Staining with anti-CD4-FITC revealed a single pop-
lation of CD4+ cells. Stimulated Mfs were washed twice with com-
lete medium prior to the addition of purified CD4+ T cells (1 × 106).
fter 5 days of incubation, nonadherent cells were transferred to
reshly stimulated Mfs (treated as above) and incubated for an-
ther 3 days. IFN-γ concentrations in the supernatants were deter-
ined by ELISA. To directly determine cytokine production from
D4+ T cells, cells were harvested, washed, counted, and restimu-
ated with PMA (50 ng/ml) and ionomycin (500 ng/ml) for 2 hr. Then,
refeldin A (10 g/ml) was added, and cells were incubated for
nother 2 hr followed by fixation, permeabilization, and analysis
ith flow cytometry as above.
eishmania infection
5aR−/− or BALB/c mice were infected intradermally with L. major
romastigotes as described (Mendez et al., 2004). In brief, L. major
lone V1 (MHOM/IL/80/Friedlin) promastigotes were grown at 26°C
n medium 199 supplemented with 20% Hi-FCS (Hyclone), 100
/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine, 40 mM
epes, 0.1 mM adenine (in 50 mM Hepes), 5 g/ml hemin (in 50%
riethanolamine), and 1 g/ml 6-biotin (M199/S). Infective-stage
romastigotes (metacyclics) of L. major were isolated from 4- to
-day-old stationary cultures by negative selection of infective
orms using peanut agglutinin (Vector Laboratories). Mice were in-
ected in the ear dermis with 105 L. major metacyclic promastigotes
sing a 27½G needle in a volume of 10 l.
arasite Quantitation
arasite loads in the ears were determined 4 weeks postinfection
s described (Mendez et al., 2004). In brief, the ventral and dorsal
heets of the infected ears were separated and deposited dermal
ide down in RPMI containing 100 U/ml penicillin, 100 g/ml strep-
omycin, and 50 g/ml of liberase CI enzyme blend (Boehringer).
ars were incubated for 40 min at 37°C. The sheets were dissoci-
ted in RPMI with 10% serum and 0.05% DNase I (Sigma), and
issue homogenates were filtered with a 70 m cell strainer (Falcon)
nd serially diluted in a 96-well flat-bottom microtiter plate contain-
ng biphasic medium (50 l NNN medium, 20% of defibrinated rab-
it blood overlaid with 100 l M199/S). The number of viable para-
ites in each ear and from local-draining lymph nodes was
etermined from the highest dilution at which promastigotes could
e grown out after 7 days of incubation at 26°C.
ytokine production after Restimulation of Lymph Node
ells from L. major-Infected Mice
or cytokine measurements in culture supernatants, cell suspen-
ions from lymph nodes of individual mice were taken 4 weeks
ostinfection and resuspended in RPMI containing FBS/pen/strept
t 6 × 106 cells/ml, and 0.1 ml was plated in 96-well U-bottom
lates. Cells were incubated at 37°C in 5% CO2 and stimulated for
2 hr with 25 g/ml soluble leishmanial antigen. IFN-γ and IL-4
evels were analyzed as described above.
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425Analysis of Dermal Lymphocytes
Single cell suspensions from the ear dermis were obtained as de-
scribed above. For the analysis of surface markers, cells were fixed
in 4% paraformaldehyde. Before staining, cells were incubated
with mAb 2.4G2 to block IgG Fc receptors and 10% normal mouse
serum in PBS containing 0.1% BSA, 0.01% NaN3. Cells were
stained for the surface markers TCR-β (H57-597, APC conjugated),
CD4 (GK1.5 FITC conjugated), and CD8 (RM4-5 and 53-6.7, cy-
chrome conjugated). Incubations were performed for 30 min on ice.
The isotype controls used were rat IgG2b (A95-1) and rat IgG2a
(R35-95) (all from BD Biosciences). The frequency of CD4+ and
CD8+ T cells was determined by gating on TCR-β+ cells. For each
sample, at least 100,000 cells were analyzed.
Statistical Analysis
Statistical analysis was performed with the SigmaStat version 2.0
statistical package (Jandel, Germany). With regard to the small
sample sizes, normal distribution was assumed. To analyze differ-
ences between two normally distributed groups, an unpaired t test
was used. Comparisons of the means of more than two normally
or nonnormally distributed groups were done by one way analysis
of variance (ANOVA) and ANOVA on ranks. When the mean values
of the groups showed a significant difference, pairwise comparison
was performed by using the Tukey test (ANOVA) or Dunn’s method
(ANOVA on ranks). p < 0.05 was considered a significant difference,
p < 0.005 was considered to be highly significant. If not stated
otherwise, data were taken from three to five individual experi-
ments and expressed as mean values ± SEM.
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